|
|
||||||||
Biology of Reproduction, Vol 20, 523-531, Copyright © 1979 by Society for the Study of Reproduction
1 Department of Animal Science,
New York State College of Agriculture and Life Sciences,
Cornell University,
Ithaca, New York 14853 The effects of various estrogen treatments on the profiles of circulating LH in ovariectomized
Beagle bitches were determined in 3 separate studies. In the first study, 13 bitches received 1-4
Silastic tubing (4.7 mm o.d.) implants of estradiol-17 Each estrogen treatment depressed LH levels within 8-24 h. Preovulatory-like LH surges were
consistently observed 26 ± 2 h following removal of estradiol implants (n = 12) and 36 ± 4 h
following a single or final EB injection (n = 25). Distinct increases in LH were seldom observed
during continued estrogen treatment and were infrequent and sporadic even in bitches in which
estradiol levels were elevated above those observed prior to ovulation in intact bitches. Progesterone administered 6 h after 66 h of EB treatment caused higher, earlier and more synchronous LH
peaks than did EB treatment alone. The results suggest that the preovulatory surge release of LH in
the bitch may be a response to withdrawal of the negative feedback effect of rising estrogen levels
and that this withdrawal effect is facilitated by the preovulatory increase in progesterone.
providing doses of 0.1-0.8 cm/kg during a
72 h period after which the accumulated treatment dose (0.1-1.2 cm/kg) was removed or reduced.
In the second study, 16 bitches received an initial estradiol benzoate (EB) injection of 2 µg/kg and
16 h later received an injection of either EB (2 µg/kg) or oil vehicle. In the third study, bitches
received EB injections every 6 h for 30 h (n = 4) or 66 h (n = 10) in increasing doses of 0.4-3.6 or
0.4-13.8 µg/kg, respectively, 4 days after receiving small implants of estradiol-17
(0.15 cm/kg).
Five bitches receiving EB for 66 h received progesterone implants (1.6 cm/kg) 6 h after the last EB
injection.
Note:
ACKNOWLEDGMENTS
The authors gratefully acknowledge the technical
assistance provided by Michael Lanieu and Donna
Young Hall and the animal care provided by Fred
Terwilliger and Dan Shattuck. The antiserum to canine
LH was provided by Dr. A. R. Boyns, Tenovus Institute, Cardiff, Wales. The purified canine LH reference
preparation was a gift of Dr. Anne Stockell-Hartree,
University of Cambridge. The antiserum to progesterone was provided by Dr. K. Kirton, The Upjohn
Company. The antiserum to estradiol was a gift of Dr.
G. D. Niswender, Colorado State University. This
research was supported by NIH-NICHD Contract No.
72-2725.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |